Application of Chickpea Extract in Preparation of Drugs for Treating Androgen-Dependent Diseases

A chickpea, extract technology, applied in the field of medicine, can solve sexual dysfunction, feminization, adverse reactions and other problems
CN108938712BActive Publication Date: 2021-04-27新疆维吾尔自治区分析测试研究院
5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
新疆维吾尔自治区分析测试研究院
Publication Date
2021-04-27

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to the application of a chickpea extract in the preparation of medicines for treating androgen-dependent diseases. The preparation of the chickpea extract is to freeze-dry, pulverize, extract and concentrate the chickpea after germination to obtain Four components of chickpea germinated hypocotyl A, germinated chickpea cotyledon B, germinated chickpea whole bean C, and chickpea ungerminated whole bean D extract were carried out through the 5α-reductase in vitro screening model Through the screening of biological activity, the better active component is postgerminated hypocotyl A of chickpea, which has broad medical application prospects in the field of drugs for treating androgen-dependent diseases.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicines, in particular to the application of chickpea extracts in the preparation of medicines for treating androgen-dependent diseases. Background technique

[0002] China has gradually entered an aging society, androgen-dependent diseases have received more and more attention, such as acne, hirsutism, androgenetic alopecia, benign prostatic hyperplasia (BPH) and prostate cancer. In particular, benign prostatic hyperplasia (BPH) is more common in middle-aged and elderly people. The incidence rate of men over 50 years old is nearly 40%, the incidence rate of men over 65 years old is nearly 70%, and the incidence rate of men over 70 years old is nearly 90%. For patients with BPH, due to the oppression of the urethra by the hypertrophy of the prostate tissue, it will cause poor urination and dysuria, and more serious cases may cause urinary retention, which is very painful for the patient. It can be seen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More